299 related articles for article (PubMed ID: 21876668)
21. CTCF regulates Kaposi's sarcoma-associated herpesvirus latency transcription by nucleosome displacement and RNA polymerase programming.
Kang H; Cho H; Sung GH; Lieberman PM
J Virol; 2013 Feb; 87(3):1789-99. PubMed ID: 23192870
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic analysis of KSHV latent and lytic genomes.
Toth Z; Maglinte DT; Lee SH; Lee HR; Wong LY; Brulois KF; Lee S; Buckley JD; Laird PW; Marquez VE; Jung JU
PLoS Pathog; 2010 Jul; 6(7):e1001013. PubMed ID: 20661424
[TBL] [Abstract][Full Text] [Related]
23. Construction of a lytically replicating Kaposi's sarcoma-associated herpesvirus.
Budt M; Hristozova T; Hille G; Berger K; Brune W
J Virol; 2011 Oct; 85(19):10415-20. PubMed ID: 21795351
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional downregulation of ORF50/Rta by methotrexate inhibits the switch of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 from latency to lytic replication.
Curreli F; Cerimele F; Muralidhar S; Rosenthal LJ; Cesarman E; Friedman-Kien AE; Flore O
J Virol; 2002 May; 76(10):5208-19. PubMed ID: 11967335
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic factor siRNA screen during primary KSHV infection identifies novel host restriction factors for the lytic cycle of KSHV.
Naik NG; Nguyen TH; Roberts L; Fischer LT; Glickman K; Golas G; Papp B; Toth Z
PLoS Pathog; 2020 Jan; 16(1):e1008268. PubMed ID: 31923286
[TBL] [Abstract][Full Text] [Related]
26. Negative elongation factor-mediated suppression of RNA polymerase II elongation of Kaposi's sarcoma-associated herpesvirus lytic gene expression.
Toth Z; Brulois KF; Wong LY; Lee HR; Chung B; Jung JU
J Virol; 2012 Sep; 86(18):9696-707. PubMed ID: 22740393
[TBL] [Abstract][Full Text] [Related]
27. Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen.
Sakakibara S; Ueda K; Nishimura K; Do E; Ohsaki E; Okuno T; Yamanishi K
J Virol; 2004 Jul; 78(14):7299-310. PubMed ID: 15220403
[TBL] [Abstract][Full Text] [Related]
28. The transcriptional repressor K-RBP modulates RTA-mediated transactivation and lytic replication of Kaposi's sarcoma-associated herpesvirus.
Yang Z; Wood C
J Virol; 2007 Jun; 81(12):6294-306. PubMed ID: 17409159
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway.
Lu F; Stedman W; Yousef M; Renne R; Lieberman PM
J Virol; 2010 Mar; 84(6):2697-706. PubMed ID: 20071580
[TBL] [Abstract][Full Text] [Related]
30. Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling.
Liang Y; Ganem D
Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8490-5. PubMed ID: 12832621
[TBL] [Abstract][Full Text] [Related]
31. Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency.
Lu F; Zhou J; Wiedmer A; Madden K; Yuan Y; Lieberman PM
J Virol; 2003 Nov; 77(21):11425-35. PubMed ID: 14557628
[TBL] [Abstract][Full Text] [Related]
32. Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway.
Lan K; Kuppers DA; Robertson ES
J Virol; 2005 Mar; 79(6):3468-78. PubMed ID: 15731241
[TBL] [Abstract][Full Text] [Related]
33. Early activation of the Kaposi's sarcoma-associated herpesvirus RTA, RAP, and MTA promoters by the tetradecanoyl phorbol acetate-induced AP1 pathway.
Wang SE; Wu FY; Chen H; Shamay M; Zheng Q; Hayward GS
J Virol; 2004 Apr; 78(8):4248-67. PubMed ID: 15047839
[TBL] [Abstract][Full Text] [Related]
34. Activation of the Kaposi's sarcoma-associated herpesvirus major latency locus by the lytic switch protein RTA (ORF50).
Matsumura S; Fujita Y; Gomez E; Tanese N; Wilson AC
J Virol; 2005 Jul; 79(13):8493-505. PubMed ID: 15956592
[TBL] [Abstract][Full Text] [Related]
35. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.
Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712
[TBL] [Abstract][Full Text] [Related]
36. Genetic disruption of KSHV major latent nuclear antigen LANA enhances viral lytic transcriptional program.
Li Q; Zhou F; Ye F; Gao SJ
Virology; 2008 Sep; 379(2):234-44. PubMed ID: 18684478
[TBL] [Abstract][Full Text] [Related]
37. Murine Gammaherpesvirus 68 Expressing Kaposi Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen (LANA) Reveals both Functional Conservation and Divergence in LANA Homologs.
Gupta A; Oldenburg DG; Salinas E; White DW; Forrest JC
J Virol; 2017 Oct; 91(19):. PubMed ID: 28747501
[TBL] [Abstract][Full Text] [Related]
38. Kaposi's Sarcoma-Associated Herpesvirus Reactivation by Targeting of a dCas9-Based Transcription Activator to the ORF50 Promoter.
Elbasani E; Falasco F; Gramolelli S; Nurminen V; Günther T; Weltner J; Balboa D; Grundhoff A; Otonkoski T; Ojala PM
Viruses; 2020 Aug; 12(9):. PubMed ID: 32867368
[TBL] [Abstract][Full Text] [Related]
39. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
Ye J; Gradoville L; Daigle D; Miller G
J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302
[TBL] [Abstract][Full Text] [Related]
40. Quantitative analysis of the bidirectional viral G-protein-coupled receptor and lytic latency-associated nuclear antigen promoter of Kaposi's sarcoma-associated herpesvirus.
Hilton IB; Dittmer DP
J Virol; 2012 Sep; 86(18):9683-95. PubMed ID: 22740392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]